Descrição
Made available in DSpace on 2022-04-29T08:37:57Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-12-07
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Monoclonal antibodies (mAbs) have been a valuable tool to elucidate several biological processes, such as stem cell differentiation and cancer, and contributed to virtually all areas of biomedical sciences. Yet, it remains a challenge to obtain mAbs specific to poorly expressed epitopes, or to epitopes that are actually involved in important biological phenomena, such as cell differentiation and metastasis. Drug-induced subtractive immunization, and recently the multiple tolerization subtractive immunization (MTSI) technique, reported by our group, have the potential to level up the field, as they direct the host´s immune response towards these epitopes. However, due to cyclophosphamide (CY) treatment, high mice mortality can be observed, and only a few data are available on how these techniques affect the immune system of mice. Tolerogen and immunogen cells, RWPE-1 and PC-3 cells, respectively, were individually seeded at 2 × 104 cells/cm2, and then adjusted to 2 × 106 cells per mouse before immunization, which was conducted in a subtractive approach (MTSI) with CY. Immunosuppression of mice was recorded via total white blood counting, as well the reactivity of circulating polyclonal antibodies (pAbs). General parameters, including weight, physical appearance, and behavior on mice subjected to three different concentrations of CY were recorded. mAbs were obtained using classical hybridoma techniques, using the spleen of immunized mice. After purification, antibodies were characterized by Western blotting, and Indirect immunofluorescence. In conclusion, all CY dosage were efficient in creating an immunosuppression state, but only the 100 mg/kg body weight was feasible, as the others resulted in extensive mice mortality. pAbs obtained in the peripheral blood of mice showed more reactivity towards tumor cells. MAbs 2-7A50 and 2-5C11 recognized antigens from tumor cells, but not from their non-tumor counterparts, as shown in western blotting and immunofluorescence assays. MTSI technique was successful in generating mAbs that recognize tumor-specific antigens.
Department of Clinical Analysis Monoclonal Antibody Laboratory School of Pharmaceutical Sciences São Paulo State University (UNESP)
Department of Morphology Extracellular Matrix Laboratory Institute of Biosciences São Paulo State University (UNESP)
Department of Urology Tissue Engineering Laboratory School of Medicine São Paulo State University (UNESP)
Department of Clinical Analysis Monoclonal Antibody Laboratory School of Pharmaceutical Sciences São Paulo State University (UNESP)
Department of Morphology Extracellular Matrix Laboratory Institute of Biosciences São Paulo State University (UNESP)
Department of Urology Tissue Engineering Laboratory School of Medicine São Paulo State University (UNESP)
FAPESP: 2017/20404-0
FAPESP: 2018/19083-7
